196 related articles for article (PubMed ID: 26882953)
1. BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.
Tu K; Liu Z; Yao B; Xue Y; Xu M; Dou C; Yin G; Wang J
Oncol Rep; 2016 Apr; 35(4):2382-90. PubMed ID: 26882953
[TBL] [Abstract][Full Text] [Related]
2. Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.
Chang W; Yu Z; Tian M; Lin X
Oncol Rep; 2017 Dec; 38(6):3489-3496. PubMed ID: 29130100
[TBL] [Abstract][Full Text] [Related]
3. Transcription Factor MafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation.
Huang XH; Jian WH; Wu ZF; Zhao J; Wang H; Li W; Xia JT
Oncotarget; 2014 Jul; 5(14):5570-80. PubMed ID: 25015194
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
Zhang L; Wang W; Li X; He S; Yao J; Wang X; Zhang D; Sun X
Int J Oncol; 2016 Jun; 48(6):2425-34. PubMed ID: 27035278
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
Yang W; Dou C; Wang Y; Jia Y; Li C; Zheng X; Tu K
Oncol Rep; 2015 Nov; 34(5):2576-84. PubMed ID: 26323375
[TBL] [Abstract][Full Text] [Related]
8. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells.
Chen J; Li X; Cheng Q; Ning D; Ma J; Zhang ZP; Chen XP; Jiang L
J Cell Biochem; 2018 Feb; 119(2):2368-2380. PubMed ID: 28885717
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
10. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.
Qin X; Li C; Guo T; Chen J; Wang HT; Wang YT; Xiao YS; Li J; Liu P; Liu ZS; Liu QY
J Exp Clin Cancer Res; 2017 Oct; 36(1):148. PubMed ID: 29052520
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.
Zhang S; Shi W; Chen Y; Xu Z; Zhu J; Zhang T; Huang W; Ni R; Lu C; Zhang X
Mol Cell Biochem; 2015 Dec; 410(1-2):1-9. PubMed ID: 26260052
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.
Bai PS; Hou P; Kong Y
Exp Cell Res; 2018 Sep; 370(1):174-188. PubMed ID: 29928866
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p42.3 promotes cell growth and tumorigenicity in hepatocellular carcinoma.
Sun W; Dong WW; Mao LL; Li WM; Cui JT; Xing R; Lu YY
World J Gastroenterol; 2013 May; 19(19):2913-20. PubMed ID: 23704824
[TBL] [Abstract][Full Text] [Related]
16. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
Geng D; Zhao W; Feng Y; Liu J
Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
[TBL] [Abstract][Full Text] [Related]
18. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
[TBL] [Abstract][Full Text] [Related]
19. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
Yan Y; Huang P; Mao K; He C; Xu Q; Zhang M; Liu H; Zhou Z; Zhou Q; Zhou Q; Ou B; Liu Q; Lin J; Chen R; Wang J; Zhang J; Xiao Z
Oncogene; 2021 Jan; 40(1):28-45. PubMed ID: 33051595
[TBL] [Abstract][Full Text] [Related]
20. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
Huang DH; Jian J; Li S; Zhang Y; Liu LZ
Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]